Table 3. The relationship between clinicopathological data of patients with HCC and the serum levels of CCL15.
| HCC | CCL15 (pg ml−1) |
|---|---|
| Total (before treatment) (55) | 26.6±1.2 |
|
Subtype
| |
| Poorly differentiated (15) | 30.3±2.2a |
| Moderately differentiated (20) | 24.3±0.6 |
| Well differentiated (20) | 19.1±0.6 |
|
Tumour size
| |
| ⩾3 cm (35) | 27.6±1.2b |
| <3 cm (20) | 19.6±2.1 |
|
Metastasis
| |
| Yes (30) | 27.9±3.6c |
| No (25) | 20.6±1.1 |
| After treatment | 9.7 ±1.2d |
| Operation (25) | 9.9±0.8 |
| Arterial embolization (20) | 10.0±1.4 |
| Percutaneous tumour ablation (10) | 9.0±1.6 |
| Healthy controls (60) | 1.2±0.1 |
Abbreviations: CCL15=C-C motif chemokine 15; HCC=hepatocellular carcinoma.
a
Showed P<0.05 between poorly differentiated and well differentiated.
b
Showed P<0.05 between tumour size ⩾3 and <3 cm.
d
Showed P<0.05 between patients with metastasis and without metastasis.
d
Showed P<0.05 between patients before and after treatments.